DocGo Company Leadership
| DCGO Stock | USD 0.81 0.01 1.22% |
About 66 percent of all DocGo's insiders are acquiring. The analysis of insiders' sentiment of trading DocGo Inc stock suggests that quite a few insiders are confidant at this time. DocGo employs about 3.4 K people. The company is managed by 17 executives with a total tenure of roughly 7943 years, averaging almost 467.0 years of service per executive, having 200.24 employees per reported executive.
Insider Sentiment 66
Mostly Buying
Selling | Buying |
Latest Trades
| 2025-05-15 | Michael J Burdiek | Acquired 15000 @ 1.43 | View | ||
| 2025-05-14 | Stephen Sugrue | Acquired 10000 @ 1.44 | View | ||
| 2024-12-16 | Ely D Tendler | Disposed 23088 @ 4.44 | View |
Monitoring DocGo's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocGo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. DocGo Management Team Effectiveness
The company has return on total asset (ROA) of (0.0947) % which means that it has lost $0.0947 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2107) %, meaning that it created substantial loss on money invested by shareholders. DocGo's management efficiency ratios could be used to measure how well DocGo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of January 2026, Return On Tangible Assets is likely to grow to 0.05. Also, Return On Capital Employed is likely to grow to 0.08. At this time, DocGo's Non Currrent Assets Other are very stable compared to the past year. As of the 29th of January 2026, Return On Tangible Assets is likely to grow to 0.05, while Total Assets are likely to drop about 339.2 M.As of the 29th of January 2026, Net Income Applicable To Common Shares is likely to grow to about 41.8 M, while Common Stock Shares Outstanding is likely to drop about 112.4 M. DocGo holds a total of 97.81 Million outstanding shares. Over half of DocGo's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 97.8 M | Current Value 115.7 M | Avarage Shares Outstanding 103.8 M | Quarterly Volatility 6 M |
DocGo Workforce Comparison
DocGo Inc is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 5,908. DocGo totals roughly 3,404 in number of employees claiming about 58% of equities under Health Care industry.
DocGo Profit Margins
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.36) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.36.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.26 | 0.31 |
|
|
DocGo Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DocGo insiders, such as employees or executives, is commonly permitted as long as it does not rely on DocGo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, DocGo insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Stephen Sugrue over a month ago Disposition of 7789 shares by Stephen Sugrue of DocGo at 3.03 subject to Rule 16b-3 | ||
Stephen Sugrue over two months ago Disposition of 5813 shares by Stephen Sugrue of DocGo at 1.52 subject to Rule 16b-3 | ||
Lee Bienstock over three months ago Disposition of 18598 shares by Lee Bienstock of DocGo at 3.35 subject to Rule 16b-3 | ||
Ely Tendler over six months ago Disposition of 10000 shares by Ely Tendler of DocGo at 1.59 subject to Rule 16b-3 | ||
Lee Bienstock over six months ago Disposition of 18597 shares by Lee Bienstock of DocGo at 1.52 subject to Rule 16b-3 | ||
Lee Bienstock over six months ago Acquisition by Lee Bienstock of 15000 shares of DocGo at 1.54 subject to Rule 16b-3 | ||
Stanley Vashovsky over six months ago Disposition of 1500000 shares by Stanley Vashovsky of DocGo subject to Rule 16b-3 | ||
Lee Bienstock over six months ago Disposition of 59360 shares by Lee Bienstock of DocGo at 3.03 subject to Rule 16b-3 |
DocGo Notable Stakeholders
A DocGo stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DocGo often face trade-offs trying to please all of them. DocGo's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DocGo's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| James MD | CEO Board | Profile | |
| Stanley Vashovsky | CoFounder Chairman | Profile | |
| Norman Rosenberg | Treasurer CFO | Profile | |
| Ben Sherman | EVP Development | Profile | |
| Anthony Capone | President | Profile | |
| Ely Tendler | Secretary Counsel | Profile | |
| Aaron Severs | Chief Officer | Profile | |
| Mike Cole | Vice Relations | Profile | |
| Lee Bienstock | Chief Officer | Profile | |
| Andre CPA | Executive Strategy | Profile | |
| Mark Merlin | LLC Holdings | Profile | |
| Ely JD | Secretary Counsel | Profile | |
| Stephen Sugrue | Chief Officer | Profile | |
| Vrenely Munoz | Chief Officer | Profile | |
| Eiwe Lingefors | Chief Officer | Profile | |
| Stan Vashovsky | Chairman CoFounder | Profile | |
| Rosemarie Milano | Vice Resources | Profile |
About DocGo Management Performance
The success or failure of an entity such as DocGo Inc often depends on how effective the management is. DocGo management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DocGo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DocGo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.05 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.06 | 0.06 |
DocGo Workforce Analysis
Traditionally, organizations such as DocGo use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DocGo within its industry.DocGo Manpower Efficiency
Return on DocGo Manpower
| Revenue Per Employee | 181.1K | |
| Revenue Per Executive | 36.3M | |
| Net Income Per Employee | 5.9K | |
| Net Income Per Executive | 1.2M | |
| Working Capital Per Employee | 53.7K | |
| Working Capital Per Executive | 10.7M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocGo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Health Care Equipment & Supplies sector continue expanding? Could DocGo diversify its offerings? Factors like these will boost the valuation of DocGo. Projected growth potential of DocGo fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DocGo data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.09 | Earnings Share (0.53) | Revenue Per Share | Quarterly Revenue Growth (0.49) | Return On Assets |
Investors evaluate DocGo Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating DocGo's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause DocGo's market price to deviate significantly from intrinsic value.
It's important to distinguish between DocGo's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DocGo should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, DocGo's market price signifies the transaction level at which participants voluntarily complete trades.